Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2015, Article ID 481621, 10 pages
http://dx.doi.org/10.1155/2015/481621
Research Article

Serum Levels of ApoA1 and ApoA2 Are Associated with Cognitive Status in Older Men

1Department of Geriatrics, Huadong Hospital, Shanghai Medical College, Fudan University, Shanghai 200040, China
2Department of Aging, Antiaging and Cognitive Function, Shanghai Institute of Geriatrics and Gerontology, Shanghai 200040, China
3Research Center of Aging and Medicine, Department of Aging and Shanghai Key Laboratory of Clinical Geriatrics, Huadong Hospital, Shanghai Medical College, Fudan University, Shanghai 200040, China

Received 15 August 2015; Revised 4 November 2015; Accepted 8 November 2015

Academic Editor: Wiep Scheper

Copyright © 2015 Cheng Ma et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Citations to this Article [10 citations]

The following is the list of published articles that have cited the current article.

  • Joseph D'Arrigo, “Nanotherapy for Early Dementia: Targeting Senile Endothelium,” SSRN Electronic Journal, . View at Publisher · View at Google Scholar
  • Joseph D'Arrigo, “Nanotherapy for Alzheimer's Disease and Vascular Dementia: Targeting Senile Endothelium,” SSRN Electronic Journal, . View at Publisher · View at Google Scholar
  • Lagai Ya, and Zuneng Lu, “Differences in ABCA1 R219K polymorphisms and serum indexes in alzheimer and parkinson diseases in Northern China,” Medical Science Monitor, vol. 23, pp. 4591–4600, 2017. View at Publisher · View at Google Scholar
  • Joseph S. D'Arrigo, “Nanotherapy for Alzheimer's disease and vascular dementia: Targeting senile endothelium,” Advances in Colloid and Interface Science, 2017. View at Publisher · View at Google Scholar
  • Joseph S. D’Arrigo, “Alzheimer’s Disease, Brain Injury, and C.N.S. Nanotherapy in Humans: Sonoporation Augmenting Drug Targeting,” Medical Sciences, vol. 5, no. 4, pp. 29, 2017. View at Publisher · View at Google Scholar
  • Matej Mihelčić, Goran Šimić, Mirjana Babić Leko, Nada Lavrač, Sašo Džeroski, and Tomislav Šmuc, “Using redescription mining to relate clinical and biological characteristics of cognitively impaired and Alzheimer's disease patients.,” PloS one, vol. 12, no. 10, 2017. View at Publisher · View at Google Scholar
  • Joseph D’Arrigo, “Targeting Early Dementia: Using Lipid Cubic Phase Nanocarriers to Cross the Blood–Brain Barrier,” Biomimetics, vol. 3, no. 1, pp. 4, 2018. View at Publisher · View at Google Scholar
  • Tian-Jun Wang, Pei-Yuan Lyu, Jing Xu, Rui Li, Yang Liu, Ming-Yue Fan, and Wei-Hong Chen, “Effects of Plasma Lipids and Statins on Cognitive Function,” Chinese Medical Journal, vol. 131, no. 4, pp. 471–476, 2018. View at Publisher · View at Google Scholar
  • Thomas Svensson, Masaru Mimura, Shoko Nozaki, Ryo Shikimoto, Norie Sawada, and Shoichiro Tsugane, “The association between midlife serum high-density lipoprotein and mild cognitive impairment and dementia after 19 years of follow-up,” Translational Psychiatry, vol. 9, no. 1, 2019. View at Publisher · View at Google Scholar
  • Suhang Shang, Pei Li, Liangjun Dang, Kang Huo, Meiying Deng, Beiyu Zhao, Jingyi Wang, Qiumin Qu, Chen Chen, Yu Jiang, and Jin Wang, “The gender- A nd age-dependent relationships between serum lipids and cognitive impairment: A cross-sectional study in a rural area of Xi'an, China 11 Medical and Health Sciences 1103 Clinical Sciences,” Lipids in Health and Disease, vol. 18, no. 1, 2019. View at Publisher · View at Google Scholar